Evidence record
Additional Actions Needed to Enhance Program Integrity and Save Billions
- Publishing agency
- U.S. Government Accountability Office
- Publication date
- April 16, 2024
- Source record
- Original document linked
Findings
5
Recommendations
5
Overall conclusion
While CMS has made significant progress in reducing improper payments and implementing GAO recommendations, ongoing efforts and additional actions are necessary to further enhance program integrity, prevent fraud, and realize substantial cost savings.
Scope
The audit covers the Medicare and Medicaid programs in fiscal year 2023, focusing on improper payments, oversight efforts, and program integrity measures, including the analysis of trends, actions taken by CMS, and recommendations for Congress and CMS to enhance oversight and reduce improper payments.
Findings (5)
Each finding has a stable link.
- F-108
The Department of Health and Human Services estimated over $100 billion in improper payments in FY 2023 for Medicare and Medicaid, representing 43% of government-wide improper payments.
- F-110
Improper payments in Medicare and Medicaid are significant, with estimates of improper payments in FY 2023 being over $51 billion for Medicare and over $50 billion for Medicaid.
- F-109
CMS has taken steps to reduce improper payments, resulting in billions of dollars in savings, including automated fraud prevention and improved oversight of managed care.
- F-111
Progress has been made in reducing improper payment rates, but substantial risks and unimplemented recommendations remain.
- F-112
CMS's efforts include improved provider screening, prepayment claim reviews, and enhanced fraud prevention systems, but some recommendations, such as legislative authority for prepayment reviews, are still pending.
Recommendations (5)
- R-130
Seek legislative authority for prepayment claim reviews in Medicare.
Related finding F-112 - R-131
Assess and optimize documentation requirements for both Medicare and Medicaid.
- R-132
Improve collaboration with state auditors and use their findings to inform oversight.
- R-133
Implement a comprehensive plan for provider revalidations post-COVID-19.
- R-129
Expand provider screening and enrollment review, especially in Medicaid.
Related finding F-110